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Management of hemodialysis catheter-related bacteremia with About 20% of the prevalent hemodialysis patients in
an adjunctive antibiotic lock solution. the United States use a tunneled central vein catheter for
Background. Tunneled dialysis catheters are complicated vascular access [1, 2]. Infections are the most serious com-by frequent systemic infections. Standard therapy of catheter-
plication of tunneled dialysis catheters. Catheter-associ-associated bacteremia involves both systemic antibiotics and
ated bacteremia occurs at a frequency of 2 to 5.5 per 1000catheter replacement. Recent data suggest that biofilms in the
catheter lumen are responsible for the bacteremia, and that in- patient-days [3–7], may be caused by both Gram-positive
stillation of an antibiotic lock (highly concentrated antibiotic and Gram-negative pathogens [5, 8], and often results in
solution) into the catheter lumen after dialysis sessions can serious systemic infections, including endocarditis, os-eradicate the biofilm.
teomyelitis, epidural abscess, septic arthritis, and evenMethods: We analyzed prospectively the efficacy of an anti-
biotic lock protocol, in conjunction with systemic antibiotics, death [5, 8]. Treatment of catheter-associated bacteremia
for treatment of patients with dialysis catheter-associated bac- with systemic antibiotics alone without catheter removal
teremia without catheter removal. Protocol success was defined is regarded as ineffective; only 22 to 37% of tunneled
as resolution of fever and negative surveillance cultures one week
catheters can be salvaged without catheter removal [3–5,following completion of the protocol. Protocol failure was de-
7, 9]. Moreover, attempting to salvage the infected cath-fined as persistence of fever or surveillance cultures positive
for any pathogen. In addition, infection-free catheter survival eter with systemic antibiotics alone, incurs the risk of
was compared to that observed in institutional historical con- serious systemic complications, including endocarditis
trol patients treated with catheter replacement. and epidural abscess [10]. For this reason, current guide-Results: Blood cultures were positive in 98 of 129 of episodes
lines recommend that dialysis-catheter associated bacter-(76%) in which patients dialyzing with a catheter had fever or
chills. Protocol success occurred in 40 of 79 infected patients emia be managed by a combination of systemic antibiot-
(51%) treated with the antibiotic lock. Protocol failure occurred ics, as well as removal of the catheter [11]. The new
in 39 cases (49%): 7 had persistent fever, 15 had positive surveil- catheter can be placed a few days after removal of the
lance cultures (9 for Candida and 6 for bacteria), and 17 re-
infected catheter, or it can be exchanged immediatelyquired catheter removal due to malfunction. Each of the patho-
over a guidewire [6, 12, 13]. Tanriover et al reportedgens in the surveillance cultures was different from the original
pathogen in that patient. Eight of the 9 secondary Candida similar infection-free survival rates with both catheter
infections and all 6 secondary bacterial infections resolved after replacement strategies [8]. However, either approach re-
catheter exchange and specific antimicrobial treatment. Overall quires an additional radiologic procedure, is costly, andcatheter survival with the antibiotic lock protocol was similar
is burdensome to the patient and the dialysis unit.to that observed among patients managed with catheter re-
placement (median survival, 64 vs. 54 days, P  0.24). Management of dialysis catheter-associated bacter-
Conclusions: Use of an antibiotic lock, in conjunction with emia would be simplified if it were possible to eradicate
systemic antibiotic therapy, can eradicate catheter-associated the source of the infection without having to replace thebacteremia while salvaging the catheter in about one half of cases.
catheter. Scanning electron microscopy demonstratesMoreover, this management approach offers clinical advan-
the presence of a biofilm coating the inner lumen in 80%tages over routine catheter exchange.
of indwelling central vein catheters within days of their
placement [14, 15]. Instillation of concentrated antibioticKey words: hemodialysis, dialysis catheter, infection, antibiotic, Can-
dida, vascular access. solutions into the lumen of silicone vascular catheters
(antibiotic lock) in vitro eliminates the biofilm [16], sug-Received for publication June 20, 2001
gesting a useful clinical application. Finally, preliminaryand in revised form October 5, 2001
Accepted for publication October 8, 2001 studies in tunneled central vein catheters used for total
parenteral nutrition [17], chemotherapy catheters [18], 2002 by the International Society of Nephrology
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and subcutaneously implanted hemodialysis vascular ac- cokinetic data in dialysis outpatients, the drug doses were
not adjusted. The bacteriologic reports were reviewedcess devices [19] have suggested that the biofilm can be
eradicated by an antibiotic lock solution instilled into the daily by the Dialysis Access Coordinators (D.C. and
L.B.). If the initial blood cultures had no growth for fivecatheter lumen, permitting bacteriologic cure without re-
placing the catheter. These type of studies have prompted days, the antibiotics were discontinued. All patients with
positive blood cultures were treated with intravenousa recent consensus panel to recommend use of antibiotic
locks for clinical management of uncomplicated bacter- antibiotics for three weeks. Once the pathogen was iden-
tified and antibiotic sensitivities available, the antibioticemia related to tunneled central vein catheters [20]. How-
ever, there are no large, prospective studies assessing the regimen was modified accordingly. Surveillance blood
cultures were obtained routinely from the patients oneefficacy of this approach in treating hemodialysis patients.
The goal of the present study was to evaluate prospec- week after completing the antibiotic lock protocol.
tively the efficacy of a defined antibiotic lock protocol for
Antibiotic lockmanagement of dialysis catheter-associated bacteremia
without catheter replacement. Both vancomycin-heparin and cefazolin-heparin locks
maintain their stability when incubated in vitro for up to
ten days in implantable venous devices [22]. In contrast,
METHODS
gentamicin is believed to be incompatible with heparin,
Patient population due to its precipitation in solution [23]. For this reason,
other investigators have prepared gentamicin antibioticThe University of Alabama at Birmingham (UAB) pro-
vides chronic dialysis to approximately 500 in-center he- locks (40 mg/mL) by using sodium citrate as a vehicle (ab-
stract; Sodemann et al, J Am Soc Nephrol 8:173A, 1997).modialysis patients. About 20% of the prevalent patients
dialyze with tunneled dialysis catheters. The demograph- Since heparin is widely used in the United States to fill
the dialysis catheters between dialysis sessions, and citrateics of the patients dialyzing with catheters are as follows:
26% of the patients are age 65 or older; 51% of the pa- is no longer commercially available for this purpose, we
re-evaluated the compatibility of gentamicin with hepa-tients are female; 84% of the patients are black and 16%
are white; and 41% of the patients have diabetes. All rin. Gentamicin at concentrations 10 mg/mL precipi-
tated immediately when mixed with heparin; however, atpatient hospitalizations, surgical procedures, and radio-
logic procedures are done at UAB Hospital. lower concentrations (4 mg/mL), the solution remained
clear for up to 72 hours of incubation at 37C. We also con-
Management of dialysis catheter-associated bacteremia firmed the compatibility in heparin (2500 units/mL) of
vancomycin (2.5 mg/mL), cefazolin (5 mg/mL), vanco-Infection was suspected clinically by the dialysis nurse
whenever patients with a dialysis catheter developed fe- mycin  gentamicin (1 mg/mL), and cefazolin  genta-
micin at 37 degrees. At these drug concentrations, whichvers or chills, in the absence of another obvious source
of infection. Treatment with empiric broad-spectrum an- are approximately 100-fold higher than the respective ther-
apeutic plasma concentrations, the antibiotics remainedtibiotics (vancomycin and gentamicin) was initiated im-
mediately after obtaining blood cultures from a peripheral in solution for up to 72 hours. Previous studies had sug-
gested that heparin inhibits the bactericidal effect ofvein, as both Gram-positive and Gram-negative organisms
grow frequently from these cultures [5, 7, 8]. Patients with gentamicin [24]. In vitro incubation with Escherichia coli
revealed that heparin partially inhibited the bactericidalclinical sepsis (some combination of high fever, persis-
tent shaking chills or hypotension) were hospitalized for action of gentamicin, but this effect was overcome at a
gentamicin concentration of 1 mg/mL (Table 1). All thefurther management, whereas those with milder symp-
toms (low grade fever and stable blood pressure) were antibiotic-heparin locks were prepared from the antibi-
otic solutions used for systemic administration (Table 2).managed as outpatients. The dialysis catheter was removed
promptly if there was a persistent fever or hemodynamic The locks were instilled into both lumens of the dialysis
catheter upon completion of each dialysis session, andinstability 48 hours after initiation of antibiotic therapy.
Patients with suspected dialysis catheter-associated bac- withdrawn immediately prior to the next dialysis session.
Once the course of antibiotics was completed, standardteremia received loading doses of vancomycin (20 mg/kg)
and gentamicin (1.5 mg/kg), followed by maintenance heparin locks were resumed.
doses of antibiotics during each of the next 8 consecutive
Data analysisdialysis sessions. The maintenance dose of vancomycin
was 500 mg [21], and the maintenance dose of gentamicin Consent for review of the patients’ medical records for
research purposes was obtained from the UAB Institu-was 1 mg/kg, but not exceeding 100 mg. Vancomycin was
infused during the last hour of dialysis, and gentamicin tional Review Board. The Access Coordinators tracked
all blood culture results, changes in antibiotics, and pa-was given immediately after completion of the dialysis
session. Due to the logistic hurdles in obtaining pharma- tient outcomes. A protocol success was defined prospec-
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Table 1. In vitro compatibility and antimicrobial activity of gentamicin with heparin
Gentamicin concentration lg/mL
0 1 4 32 128 1000
No heparin 0.570.04 0.280.02 0.140.01 0.060 0.060 0.060
Heparin 0.160.01 0.150.01 0.150.01 0.110 0.060.02 0.060
The values in the Table are absorbance ( SD) at OD 600 nm. Using the broth macrodilution technique, sodium heparin was added to vials containing various
concentrations of gentamicin. A standardized suspension of E. coli was added to each tube to obtain a final concentration of 4.5  105 CFU/mL. The final heparin
concentration was 2500 U/mL in all vials. After a 48 hour incubation at 37C, the visible turbidity was determined as the absorbance measured at OD 600 nm. The
MIC was defined as the lowest concentration at which no bacterial growth occurred, as evidenced by the absence of turbidity (absorbance  0). In the absence of
gentamicin, heparin partially inhibited bacterial growth. Heparin partially inhibited the antimicrobial effect of gentamicin, but this inhibition was overcome at a
gentamicin concentration of 1 mg/mL.
Table 2. Preparation of the antibiotic lock solution RESULTS
Volume of solution mL During the six-month period from June 1, 2000 to
Type of lock solution Vanca Gentb Cefazc Heparind NS November 30, 2000, a total of 129 episodes of catheter-
related bacteremia were suspected on clinical groundsVancomycin/gentamicin 1.0 0.5 — 0.5 —
Vancomycin 1.0 — — 0.5 0.5 (Fig. 1). In 31 cases the blood cultures were negative at
Gentamicin — 0.5 — 0.5 1.0 five days, the antibiotics discontinued, and the catheterCefazolin — — 1.0 0.5 0.5
continued to be used. Blood cultures from the remainingCefazolin/gentamicin — 0.5 1.0 0.5 —
98 episodes yielded a total of 124 pathogens, resultingThe antibiotic/heparin lock solutions were prepared from the following solu-
tions used for systemic administration of antibiotics: a vancomycin, 5 mg/mL (in in an overall dialysis catheter-associated infection rate
NS, normal (0.9%) saline); b gentamicin, 4 mg/mL (in NS); c cefazolin, 10 mg/mL
of 5.4 per 1000 patient-days. A single Gram-positive coc-(in NS); d heparin, 10,000 units/mL. The final drug concentrations in the antibiotic
lock solutions was: vancomycin, 2.5 mg/mL, gentamicin, 1 mg/mL, cefazolin, 5 cus grew in 50% of the cases, a single Gram-negative or-
mg/mL, and heparin, 2500 units/mL.
ganism grew in 30% of the cases, and 20% of positive
cultures yielded two or more organisms. Of the 124
pathogens grown from blood cultures, 61% were Gram-
positive cocci, and 39% were Gram-negative rods. Thetively as catheter salvage with resolution of symptoms
Gram positive organisms consisted largely of Staphylo-within 48 hours of initiation of the antibiotic lock proto-
coccal species (63%) and Enterococcus (30%), with the re-col and negative surveillance cultures one week after com-
maining comprised of Streptococcal species (7%). Aboutpleting the antibiotic regimen. A protocol failure was
63% of the Staphylococcal species were methicillin resis-defined as (1) persistent fever or hemodynamic instabil-
tant. The Gram negative organisms included Klebsiellaity	48 hours after initiation of the antibiotic lock proto-
(29%), Enterobacter (25%), Serratia (13%), E. coli (11%),col or (2) post-treatment surveillance cultures positive
Proteus (8%), Acinetobacter (6%), Stenotrophomonasfor any organism. Catheters that were removed for non-
(4%), Citrobacter (2%), and Morganella (2%).infectious reasons before completion of the antibiotic
Thirty-six episodes of positive blood cultures were ex-lock protocol were excluded from this analysis.
cluded from analysis because (1) the catheter was re-Survival analysis techniques were used to model infec-
moved for noninfectious reasons prior to completing thetion-free catheter survival from the time of initiation of
antibiotic lock protocol, (2) the catheter was removedthe antibiotic lock protocol. Patients whose catheter mal-
without attempting the antibiotic lock protocol, (3) therefunctioned, was electively removed (permanent vascular
was an incomplete patient follow-up, or (4) the cultureaccess ready to use), or who died with a functioning cathe-
grew Candida (Fig. 1). Of the remaining 62 episodes,ter were considered censored. Survival distributions were
40 cases (64.5%) were protocol successes (the patientplotted using the Kaplan Meier curve. We compared cathe-
remained asymptomatic with negative surveillance cul-ter survival with this protocol to that previously reported
tures and the catheter was salvaged). The remaining 22from our institution for 69 non-concurrent, historical pa-
cases (35.5%) were considered protocol failures. Thetients whose catheter-related bacteremia was managed
success rate of the protocol, sorted by pathogen (Ta-with catheter replacement (either exchange over a guide-
ble 3), was similar for Gram-positive and Gram-negativewire or removal with delayed placement of a new cathe-
infections [odds ratio (OR) 1.22; 95% confidence intervalter) [8]. Because of the possibility that some catheter mal-
(CI) 0.49 to 3.08, P  0.66]. If catheter dysfunction wasfunctions could be related to infection, we repeated the
catheter survival analysis with both infection and mal- included as a catheter failure, the success rate of the
protocol was 51% (40 of 79 catheters).function being considered as catheter failures. The log
rank test was used to compare catheter survival between The protocol failures included seven patients whose
fever persisted longer than 48 hours after initiation ofthe two treatment groups.
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Fig. 1. Clinical outcomes of all episodes of di-
alysis catheter-related bacteremia during a six-
month period.
the antibiotic lock protocol, and 15 who had positive sur-
veillance cultures one week after completing the antibi-
otic course (Fig. 1). The latter included 6 patients whose
Table 3. Outcomes of episodes of catheter-associated bacteremia surveillance cultures grew a new bacterial pathogen, and
treated with the antibiotic lock protocol 9 who grew Candida. Thus, all 15 positive surveillance cul-
Success tures obtained one week after completing the three-week
protocol grew a new pathogen, different from that pres-Pathogena N catheters N %
ent in the initial blood culture. Of the 15 patients withGram positive cocci 44 28 64
Staphylococcus 29 20 69 positive surveillance cultures, 14 were asymptomatic and
MRSE 19 15 79 one had septic Candida arthritis. Eight of the 9 Candida
MSSE 6 4 67
infections were treated by catheter exchange, as well asMRSA 1 0 0
MSSA 1 0 0 anti-fungal therapy (fluconazole or amphotericin for 2
Other 2 1 50 weeks); in all cases the subsequent surveillance culturesEnterococcus 12 5 42
obtained one week after completing the anti-fungal med-Strep species 3 3 100
Gram-negative rods 34 20 59 ication were negative. The ninth patient with secondary
Klebsiella 12 8 66 Candida infection died of bacterial endocarditis beforeEnterobacter 8 6 75
completing the course of anti-fungal therapy. All 6 pa-Serratia 5 1 20
Stenotrophomonas 2 1 50 tients whose surveillance cultures were positive for a
Acenitobacter 2 1 50
bacterial pathogen were treated with a catheter exchangeE. coli 2 1 50
Proteus 2 1 50 as well as systemic antibiotics, and had negative blood
Citrobacter 1 1 100 cultures subsequently.
Bacteriologic success was defined as absence of recurrent fever and negative Five of the 9 patients whose surveillance cultures grew
surveillance cultures after completion of the protocol. Abbreviations are: MRSE,
Candida had been treated with broad spectrum antibiot-methicillin-resistant Staph epidermidis; MSSE, methicillin-sensitive Staph epider-
midis; MRSA, methicillin-resistant Staph aureus; MSSA, methicillin-sensitive Staph ics (vancomycin and gentamicin) for three weeks due to
aureus.
a Some episodes of bacteremia were associated with 	1 pathogen an initial enterococcal bacteremia. The likelihood of a sec-
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Fig. 2. Life-table analysis (Kaplan Meier sur-
vival curves) for infection-free catheter sur-
vival among patients whose initial episode of
catheter-related bacteremia was treated with
one of two strategies: antibiotic lock protocol
without catheter replacement (solid line) or
replacement of the infected catheter (dashed
line) (P  0.57).
ondary Candida infection was 42% when the original days for patients treated with catheter replacement (P
0.57). Re-analysis of the data with catheter failure beingpathogen was Enterococcus, as compared with 8% for
all other pathogens (OR 8.21, 95% CI 1.77 to 38.18, P  defined as infection or malfunction also showed similar
overall catheter survival for the two treatment groups0.003). In addition, two patients with Candidemia had
been on chronic immunosuppressive medications (one (Fig. 3). In this analysis, catheter survival was 64 days
for patients treated with the antibiotic lock protocol andfor myasthenia gravis, and one for polyneuropathy).
Among the 62 patients with documented catheter-asso- 54 days for patients treated with catheter replacement
ciated bacteremia enrolled in the antibiotic lock proto- (P  0.24).
col, serious systemic complications occurred in 11 cases,
or 18% of the total. These complications included septic
DISCUSSIONshock in 5 patients, septic arthritis in 2 patients (one of
The antibiotic lock protocol was successful in achiev-whom also had septic shock), endocarditis in 3 cases, and
ing a clinical and bacteriologic cure of dialysis catheter-spinal osteomyelitis in one patient. In addition, one pa-
associated bacteremia in 64.5% of the patients enrolledtient required mechanical ventilation due to respiratory
in this study, without requiring catheter replacement.failure. Six of the infections resulting in serious systemic
Treatment with systemic antibiotics alone (without cath-complications were caused by Gram-negative organisms
eter replacement) is rarely successful in salvaging an in-(3 Serratia, 2 Enterobacter, and 1 Klebsiella), and five
fected catheter [3–5, 9], most likely because it does notwere due to Gram-positive infections (3 Staphylococcus
eradicate the biofilm responsible for the bacteremia [14,and 2 Enterococcus). The frequency of serious systemic
15]. For this reason, the current standard of care is tocomplications with catheter-related bacteremia was not
replace the infected catheter [11]. In the absence of ansignificantly different with Gram-negative versus Gram-
antibiotic lock, the antibiotic levels within the catheterpositive infections (18 vs. 11%, P  0.43).
are negligible during systemic administration of the drug,Infection-free catheter survival after initiation of the
and are inadequate to treat this source of the infectionantibiotic lock protocol was compared to that previously
[25]. The antibiotic lock solutions used in the currentobserved in non-concurrent control patients treated with
study are about 100-fold higher than therapeutic plasmacatheter replacement. The patients in the two treatment
concentrations, and thereby adequate to eradicate thegroups were similar in terms of their mean age (55 
biofilm, without requiring removal of the catheter. Seri-14 vs. 52  16 years), proportion of females (48% vs.
ous systemic complications occurred in 18% of the cases51%), proportion of blacks (80% vs. 84%), and propor-
tion of diabetics (45% vs. 41%). The survival curves for treated with the antibiotic lock protocol. This frequency
is comparable to the 19% rate of serious complicationsthe two treatment groups were very similar (Fig. 2). The
median infection-free catheter survival was 70 days for observed at our institution when prompt catheter re-
placement was employed [8], suggesting that the anti-patients treated with the antibiotic lock protocol and 71
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Fig. 3. Life-table analysis (Kaplan-Meier
survival curves) for overall catheter sur-
vival among patients whose initial episode
of catheter-related bacteremia was treated
with one of two strategies: antibiotic lock
protocol without catheter replacement (solid
line) versus replacement of the infected cathe-
ter (dashed line). Catheter failures included
infection or dysfunction (P  0.24).
biotic lock protocol does not increase the risk of serious During this six-month period of prospective data col-
lection, we observed an overall catheter-associated infec-complications.
Few studies have examined the use of antibiotic locks tion rate of 5.4 per 1000 patient-days, comparable to the
range of 2 to 5.5 per 1000 patient days described in pre-for treatment of tunneled central venous catheter infec-
tions. Messing et al achieved a bacteriologic cure in 10 vious published series [3–7]. The presence of fever or
chills among patients with a dialysis catheter who did notof 11 (91%) catheters used for total parenteral nutrition
[17]. Panagea and Galloway successfully used an anti- have another obvious source of infection was associated
with positive blood cultures in 76% of cases. The highbiotic lock to treat bacteremia associated with chemo-
therapy catheters in 17 of 22 cases (77%) [18]. Finally, likelihood of bacteremia and the wide variety of poten-
tial pathogens supports empiric initiation of broad-spec-Boorgu et al reported successful eradication of bacter-
emia with the antibiotic lock in 14 of 14 (100%) hemodi- trum antibiotic therapy in these patients. Follow-up of
the blood culture results permitted early discontinuationalysis patients dialyzing with a subcutaneous vascular
access device [19]. The current study observed a bacterio- of antibiotics at day 5 in culture negative patients (about
one quarter of the cases). Moreover, in the majority oflogic cure in 40 of 62 (64.5%) of patients with dialysis
catheter-associated bacteremia treated with an antibiotic patients with positive blood cultures, it was possible to
switch to narrower spectrum antibiotic regimen withinlock protocol. Among the 15 patients with positive sur-
veillance cultures, each grew a different organism than a few days, once the antibiotic sensitivities of the patho-
gens has been elucidated. Successful achievement of thesethat present in the initial blood cultures, suggesting that
the original infection had been eradicated, and the pa- goals was expedited by centralized monitoring of the pro-
tocol by Dialysis Access Coordinators, under the super-tient had a new infection.
The results observed in the current study are in agree- vision of a nephrologist [26].
The surveillance cultures were positive for Candidament with the recent recommendations by the consensus
panel on the management of uncomplicated infections species in 9 of 62 (14%) of the patients enrolled in the
antibiotic lock protocol. Similarly, Messing et al reportedrelated to tunneled central vein catheters [20]. The con-
sensus panel also recommended that when the infection a 9% frequency of secondary Candida infections among
a group of home parenteral nutrition patients whoseis due to Staphylococcus aureus, catheter salvage with the
antibiotic lock should only be attempted if a transesopha- catheter-associated bacteremia was treated with an anti-
biotic lock [17]. Only one of the 9 patients with secondarygeal echocardiogram does not show vegetations. Only
two infections in the present study were due to Staphylo- Candidemia in the present study was symptomatic or ex-
hibited evidence of metastatic infection. Furthermore,coccus aureus (Table 3), and neither responded to the
antibiotic lock protocol. Finally, the three-week course of catheter exchange in conjunction with anti-fungal ther-
apy (fluconazole or amphotericin) was uniformly success-antibiotics used in the current study is longer than the
two-week course recommended by the consensus panel. ful in eradicating the fungemia. Most patients with can-
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central venous hemodialysis catheters inserted percutaneously.didemia following their antibiotic lock protocol could be
J Am Soc Nephrol 4:1719–1725, 1994
predicted, because they had received broad-spectrum anti- 4. Lund GB, Trerotola SO, Scheel PF, et al: Outcome of tunneled
hemodialysis catheters placed by radiologists. Radiology 198:467–biotic therapy (vancomycin gentamicin) for three weeks
472, 1996due to an enterococcal infection or had been on concomi-
5. Marr KA, Sexton DJ, Conlon PJ, et al: Catheter-related bacter-
tant immunosuppressive therapy. In dialysis patients emia and outcome of attempted catheter salvage in patients under-
going hemodialysis. Ann Intern Med 127:275–280, 1997with these risk factors, it might be preferable to proceed
6. Beathard GA: Management of bacteremia associated with tun-with prompt catheter exchange, rather than attempt to neled-cuffed hemodialysis catheters. J Am Soc Nephrol 10:1045–
salvage the catheter with an antibiotic lock protocol. Of 1049, 1999
7. Saad TF: Bacteremia associated with tunneled, cuffed hemodialy-interest, after we adopted this revised protocol, only 1
sis catheters. Am J Kidney Dis 34:1114–1124, 1999of 61 patients (1.7%) of patients with catheter-related 8. Tanriover B, Carlton D, Saddekni S, et al: Bacteremia associated
bacteremia who were treated with the antibiotic lock with tunneled dialysis catheters: Comparison of two treatment
strategies. Kidney Int 57:2151–2155, 2000developed subsequent fungemia.
9. Pourchez T, Moriniere P, Fournier A, Pietri J: Use of PermcathIn summary, prospective evaluation of our antibiotic (Quinton) catheter in uremic patients in whom the creation of con-
ventional vascular access for hemodialysis is difficult. Nephron 53:lock protocol suggests that dialysis catheter-associated
297–302, 1989bacteremia can be eradicated in about two-thirds of cases,
10. Kovalik EC, Raymond JR, Albers FJ, et al: A clustering of epidural
without requiring removal of the infected catheter. If the abscesses in chronic hemodialysis patients: Risks of salvaging access
catheters in cases of infection. J Am Soc Nephrol 7:2264–2267, 1996culture-negative cases are included in the analysis, 71 of
11. NKF-DOQI Clinical Practice Guidelines for Vascular Ac-93 (76%) of catheters with suspected bacteremia were cess: Guideline 26: Treatment of infection of tunneled dialysis cathe-
salvaged by this treatment protocol. Moreover, the delay ters. Am J Kidney Dis 37(Suppl 1):S166, 2001
12. Shaffer D: Catheter-related sepsis complicating long-term, tun-in removal of catheters among patients who fail to re-
neled central venous dialysis catheters: Management by guidewirespond to the protocol did not increase the risk of serious exchange. Am J Kidney Dis 25:593–596, 1995
infectious complications. Successful treatment of an epi- 13. Robinson D, Suhocki P, Schwab SJ: Treatment of infected tunneled
venous access hemodialysis catheters with guidewire exchange. Kid-sode of catheter-associated bacteremia with the antibi-
ney Int 53:1792–1794, 1998
otic lock protocol did not preclude a subsequent episode 14. Passerini L, Lam K, Costerton JW, King EG: Biofilms on indwell-
ing vascular catheters. Crit Care Med 20:665–673, 1992(Fig. 2). However, the likelihood of a subsequent infec-
15. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: Ation was no different than that observed among patients common cause of persistent infections. Science 284:1318–1322, 1999
whose initial infection was treated with catheter replace- 16. Andris DA, Krzywda EA, Edmiston CE, et al: Elimination of
intraluminal colonization by antibiotic lock in silicone vascularment. The ability to resolve most cases of dialysis cathe-
catheters. Nutrition 14:427–432, 1998ter-related bacteremia without removal of the infected 17. Messing B, Peitra-Cohen S, Debure A, et al: Antibiotic-lock
technique: A new approach to optimal therapy for catheter-relatedcatheter may result in a substantial economic benefit.
sepsis in home-parenteral nutrition patients. J Parenter Enteral
Nutr 12:185–189, 1988
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